Literature DB >> 21899763

How often is a work-up for Legionella pursued in patients with pneumonia? a retrospective study.

Brian Hollenbeck1, Irene Dupont, Leonard A Mermel.   

Abstract

BACKGROUND: It is unclear how often patients with pneumonia are assessed for Legionella in endemic areas. Additionally, the sensitivity of the IDSA/ATS criteria for recommended Legionella testing is undefined.
METHODS: We performed a single-center, retrospective study of patients diagnosed with Legionella pneumonia at our hospital to determine: 1) how often Legionella diagnostic testing is obtained on patients with pneumonia at the time of hospitalization or when pneumonia developed during hospitalization; and 2) how often patient's with Legionella pneumonia met at least one of the five criteria in the IDSA/ATS guidelines recommending a work-up for Legionella. Patients with Legionella pneumonia were identified using an infection control software program. Medical records of these patients were then reviewed.
RESULTS: Thirty-five percent of patients with a discharge diagnosis of pneumonia had Legionella urine antigen testing and/or a Legionella culture performed. Forty-four percent of patients who had a bronchoscopic specimen sent for microbiologic testing had a Legionella culture performed on the bronchoscopic specimen and/or Legionella urine antigen testing. Of 37 adult patients with Legionella pneumonia, 22 (59%) met the IDSA-ATS criteria recommending Legionella testing.
CONCLUSION: Following current recommendations for Legionella testing missed 41% of Legionella cases in adults in our single-center study. A work-up for Legionella (i.e., urine antigen test and/or culture) was performed in less than half of patients who have a bronchoscopic specimen sent for microbiologic testing.

Entities:  

Mesh:

Year:  2011        PMID: 21899763      PMCID: PMC3175219          DOI: 10.1186/1471-2334-11-237

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  5 in total

1.  Sensitivity of three urinary antigen tests associated with clinical severity in a large outbreak of Legionnaires' disease in The Netherlands.

Authors:  Ed P F Yzerman; Jeroen W den Boer; Kamilla D Lettinga; Joop Schellekens; Jacob Dankert; Marcel Peeters
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

2.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

3.  Pneumonia due to Legionella pneumophila and pneumococcal pneumonia: similarities and differences on presentation.

Authors:  A Granados; D Podzamczer; F Gudiol; F Manresa
Journal:  Eur Respir J       Date:  1989-02       Impact factor: 16.671

4.  Increasing incidence of legionellosis in the United States, 1990-2005: changing epidemiologic trends.

Authors:  Karen Neil; Ruth Berkelman
Journal:  Clin Infect Dis       Date:  2008-09-01       Impact factor: 9.079

5.  Comparative study of Legionella pneumophila and other nosocomial-acquired pneumonias.

Authors:  J Roig; X Aguilar; J Ruiz; C Domingo; E Mesalles; J Manterola; J Morera
Journal:  Chest       Date:  1991-02       Impact factor: 9.410

  5 in total
  9 in total

1.  Population-Based Assessment of Clinical Risk Factors for Legionnaires' Disease.

Authors:  Laura A Cooley; Tracy Pondo; Louise K Francois Watkins; Priti Shah; Stephanie Schrag
Journal:  Clin Infect Dis       Date:  2020-05-23       Impact factor: 9.079

2.  Pneumococcal and Legionella Urinary Antigen Tests in Community-acquired Pneumonia: Prospective Evaluation of Indications for Testing.

Authors:  Shawna Bellew; Carlos G Grijalva; Derek J Williams; Evan J Anderson; Richard G Wunderink; Yuwei Zhu; Grant W Waterer; Anna M Bramley; Seema Jain; Kathryn M Edwards; Wesley H Self
Journal:  Clin Infect Dis       Date:  2019-05-30       Impact factor: 9.079

3.  Legionnaires' Disease Outbreaks and Cooling Towers, New York City, New York, USA.

Authors:  Robert Fitzhenry; Don Weiss; Dan Cimini; Sharon Balter; Christopher Boyd; Lisa Alleyne; Renee Stewart; Natasha McIntosh; Andrea Econome; Ying Lin; Inessa Rubinstein; Teresa Passaretti; Anna Kidney; Pascal Lapierre; Daniel Kass; Jay K Varma
Journal:  Emerg Infect Dis       Date:  2017-11       Impact factor: 6.883

4.  Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study.

Authors:  Manuela Carugati; Stefano Aliberti; Luis Felipe Reyes; Ricardo Franco Sadud; Muhammad Irfan; Cristina Prat; Nilam J Soni; Paola Faverio; Andrea Gori; Francesco Blasi; Marcos I Restrepo
Journal:  ERJ Open Res       Date:  2018-10-08

Review 5.  Global Perspective of Legionella Infection in Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Frances F Graham; Norah Finn; Paul White; Simon Hales; Michael G Baker
Journal:  Int J Environ Res Public Health       Date:  2022-02-08       Impact factor: 3.390

Review 6.  Legionellosis on the Rise: A Review of Guidelines for Prevention in the United States.

Authors:  Alyssa Parr; Ellen A Whitney; Ruth L Berkelman
Journal:  J Public Health Manag Pract       Date:  2015 Sep-Oct

Review 7.  Diagnostic testing for Legionnaires' disease.

Authors:  David M Pierre; Julianne Baron; Victor L Yu; Janet E Stout
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-08-29       Impact factor: 3.944

8.  Clinical Presentation of Community-Acquired Legionella Pneumonia Identified by Universal Testing in an Endemic Area.

Authors:  Shruti Puri; Monique Boudreaux-Kelly; Jon D Walker; Cornelius J Clancy; Brooke K Decker
Journal:  Int J Environ Res Public Health       Date:  2020-01-15       Impact factor: 3.390

9.  Evaluation of the national surveillance of Legionnaires' disease in Norway, 2008-2017.

Authors:  Cecilia Wolff; Heidi Lange; Siri Feruglio; Line Vold; Emily MacDonald
Journal:  BMC Public Health       Date:  2019-12-03       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.